GLORIA DIENERT: Open Payments
NPI 1962786814 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 93 payments from 26 companies in 2025. Trend: 2023 $2,144 · 2024 $1,479 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $232 |
| GlaxoSmithKline, LLC. | 13 | $194 |
| EMD Serono, Inc. | 9 | $163 |
| ABBVIE INC. | 11 | $141 |
| Biogen, Inc. | 5 | $102 |
| Axsome Therapeutics, Inc. | 2 | $99 |
| ARGENX US, INC. | 4 | $84 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| Celgene Corporation | 3 | $67 |
Products named: NURTEC ODT, NUCALA, TYSABRI, Symbravo, VYVGART HYTRULO, INGREZZA, PONVORY, UBRELVY.
Industry payments across TX — which companies pay providers there.
